To refine your search through our archives use our Advanced Search
A major apartment fire on the east side displaced 30 people Tuesday night. Fire crews responded about 8:20 p.m. to the Spanish Oaks Apartments, but were delayed by about 10 minutes by frozen hydrants. By that time, the fire had burned through a large section of the roof. No injuries were reported. Firefighters said they had a difficult time interviewing residents about the cause of the fire because most of them were Hispanic and spoke little English.
Indianapolis police took three people into custody Wednesday following an early-morning home invasion on the north side. A neighbor called 911 after seeing the three suspects kicking down the front door of a home on the 5000 block of Kingsley Drive just after midnight. Police say the suspects showed a gun and demanded money from the three elderly residents. The suspects were still inside the home when police arrived and tried to hide in the basement. No injuries were reported.
Ball State University has signed a contract to move its Sept. 3 football season-opener against Indiana University from Muncie to Indianapolis.
Members of Congress are asking the SBA to look for efficiencies. How any fallout will affect lending is up in the air.
A group of entrepreneurs plans to open Fountain Square Brewing Co., possibly this summer, in a former carburetor-repair shop.
The Wigwam at Anderson High School is the second-largest high school gymnasium in the world, second only to the Fieldhouse in New Castle.
Improvements, which include nine new cell towers and more Wi-Fi coverage, are expected to be made before Indianapolis hosts next year’s Super Bowl.
How is talk-radio host Abdul-Hakim Shabazz like the Wizard of Oz? Were his barbs about an IPS official "over the top"? Does he really have the governor’s ear? He's taking your calls.
Carmel-based team is building a 12,000-square-foot addition at its headquarters that will house a state-of-the-art machine shop outfitted with high-tech milling machines manufactured by Indianapolis-based Hurco Cos.
Maryland-based defense contractor Gryphon Technologies plans to expand its operations in Bloomington, creating as many as 60 jobs by 2013.
A South Bend firm has a bishop’s go-ahead to publish a $1.99 iPhone application to help Catholics through the process of confession.
Under the bill, couples who complete premarital classes would pay the standard $18 fee for a marriage license and certificate. But couples that don't take a course would pay $72.
More than 1,000 Indiana teachers swarmed the Indiana Statehouse Tuesday for a rowdy rally denouncing the sweeping education proposals moving through the Republican-dominated state House and Senate.
The House approved the proposal Tuesday on a 59-37 mostly party-line vote following hours of debate. Republicans say the bill would mean more options for families, while Democrats contend that it will erode funding for traditional schools.
Managed Health Services, a unit of St. Louis-based Centene Corp., named Scott Linneweber its director of compliance. Linneweber was previously a staff attorney for the Indiana Family and Social Services Administration. Managed Health Services has contracts with FSSA to administer health benefits to Hoosiers under the Hoosier Healthwise Medicaid program and the Healthy Indiana Plan.
St. Vincent Jennings Hospital in North Vernon announced that Carl W. Risk II is its new administrator. Risk was most recently vice president of clinical services at King’s Daughters’ Hospital and Health Services in Madison, Ind. In that capacity, he led the development and execution of the hospital’s strategic plan and managed the operations and financials for the following service areas: medical imaging, laboratory, cardio-pulmonary, pharmacy, rehabilitation, marketing and community relations; and the foundation.
Boy does Gov. Mitch Daniels have an ultimatum for President Obama: Wave off the health reform law or else I’ll do nothing to help while it wreaks havoc on Hoosier citizens.
Eli Lilly and Co. can be credited with using acquisitions to unclog its product pipeline. It launched two drugs in the past 18 months, won market approval for a third and will likely get nods for two more drugs this year. Trouble is, they all have paltry sales prospects.
Indiana University has created the Indiana Institute for Personalized Medicine, with $11.25 million in funding from its School of Medicine, its IUPUI campus, the Indiana Physician Scientist Initiative and the Melvin and Bren Simon Cancer Center. The newly created institute will conduct research and work to develop tools that help health care providers select the best medicines for patients based on their genetic traits. “Much of the future of health care is in personalized medicine, meaning more precise targeting of the right medication to the right patient at the right time,” said Dr. David Flockhart, an IU professor of cancer epidemiology and genetics who has been named director of the institute.
Eli Lilly and Co. and the Juvenile Diabetes Research Foundation have agreed to to spend $1.4 million over three years to fund the research at University of Geneva that could help patients with type 1 diabetes to regenerate insulin-producing cells destroyed by the disease. Previous research by Geneva’s Pedro Herrera showed the possibility of converting pancreas cells that do not produce insulin into insulin-producing cells—and to do so without genetic manipulation. Researchers at Indianapolis-based Lilly will now collaborate with Herrera to find potential targets in the pancreas that when exposed to a drug would induce this cell conversion. Lilly hopes to be able to then develop drugs that could treat type 1 diabetes and, perhaps, eliminate the need for insulin therapy.
Endocyte Inc. went public on Friday, selling 12.5 million shares at $6 apiece. The price has since risen to about $7.30. The West Lafayette-based drug-development company twice cut the price of its offering last week. It had intended to sell about 5.4 million shares for a range of $13 to $15 apiece. The underwriters of Endocyte’s IPO have an option to buy an additional 1.8 million shares, which could bring Endocyte’s total sale to $86 million. Including the underwriters' options, the company could see proceeds of up to $86.3 million. The company, which has no sales to date, intends to use all the money from the sale to advance development on its experimental drugs. Its lead product candidate, EC145, is a potential cancer treatment. The company hopes to move it into late-stage development as a potential ovarian cancer treatment. Endocyte is trading under the "ECYT" symbol on Nasdaq.
Indianapolis-based Medical Animatics sold some of its assets to Indianapolis-based Harrison College. The deal included three master-level designers, animation equipment and portions of Medical Animatics’ illustration libraries. Harrison, formerly known as the Indiana Business College, intends to use the assets to develop content for its online, on-ground and blended courses. Medical Animatics, which had made instructional courses for health care clients, had helped Harrison design an online medical assisting program, which launched in January. Harrison did not purchase the full agency or its name, and will not assume any of the company’s liabilities. Medical Animatics founder Harlon Wilson said the company is looking to take its work into new markets.
Bioanalytical Systems Inc. swung to a profit in its most recent quarter. The West Lafayette-based provider of pharmaceutical testing equipment and services earned $310,000, or 6 cents per share, in the three months ended Dec. 31. In the same quarter a year ago, the company lost $1.5 million, or 30 cents per share. Revenue for the most recent quarter totaled $8.1 million, a 27-percent increase from a year ago, as pharmaceutical companies renewed their research and development spending. Bioanalytical also trimmed $265,000 in expenses in the past year.
Indianapolis-based Dow AgroSciences boosted its fourth-quarter revenue by 19 percent to $1.3 billion, compared with the same quarter a year ago. Quarterly earnings before interest, taxes, depreciation and amortization also edged up from $69 million to $72 million. Dow Agro’s overhead expenses increased 3 percent during the quarter because of new product launches and commercial activities related to recent seed acquisitions. It also spent 14 percent more on research and development. Dow Agro is a unit of Midland, Mich.-based Dow Chemical Co.
